Literature DB >> 6982088

Remission induction in a patient with severe aplastic anemia and renal failure by immunosuppressive treatment including antithymocyte globulin.

H G Hartmann, H W Pees, G A Jutzler, P G Scheurlen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6982088     DOI： 10.1007/BF00320195

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  13 in total

Review 1.  Drug-induced aplastic anemia.

Authors:  D M Williams; R E Lynch; G E Cartwright
Journal:  Semin Hematol       Date:  1973-07       Impact factor: 3.851

2.  Aplastic agranulocytosis after allopurinol therapy.

Authors:  M S Greenberg; S S Zambrano
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

3.  Bolus methylprednisolone in severe aplastic anemia.

Authors:  A Bacigalupo; D Giordano; M T Van Lint; R Vimercati; A M Marmont
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

4.  Heterogeneity of pathogenetic mechanisms in aplastic anemia. Efficacy of therapy based on in-vitro results.

Authors:  N I Abdou; J D Verdirame; M Amare; N L Abdou
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

5.  Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.

Authors:  B Speck; A Gratwohl; C Nissen; U Leibundgut; D Ruggero; B Osterwalder; H P Burri; P Cornu; M Jeannet
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

6.  Reversible flu-like syndrome, leukopenia, and thrombocytopenia induced by allopurinol.

Authors:  D Rosenbloom; R Gilbert
Journal:  Drug Intell Clin Pharm       Date:  1981-04

7.  Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; H J Deeg; A Fefer; B W Goodell; G E Sale; J E Sanders; J Singer; P Stewart; P L Weiden
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

8.  Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia.

Authors:  M M Bortin; R P Gale; A A Rimm
Journal:  JAMA       Date:  1981-03-20       Impact factor: 56.272

9.  Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.

Authors:  A Bacigalupo; M Podestà; M C Mingari; L Moretta; M T Van Lint; A Marmont
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  [Bone marrow transplantation for aplastic anaemia (author's transl)].

Authors:  H J Kolb; G F Wündisch; I Spitzer; H Ochsler; L Stengel-Rutkowski; C Bender-Götze; E D Albert; H Sauer; G Ledderose; G Brehm; U Jehn; R Eckstein; W Mempel; W Wilmanns; R J Haas; M Helmig; B Netzel; B Belohradsky; G Janka; H Rodt; H Grosse-Wilde; E Thiel; H von Lieven; R Roloff; B L Krimmel; E Bunde; R Wank; D Schendel
Journal:  Klin Wochenschr       Date:  1981-04-01
View more
  3 in total

1.  Successful immunosuppressive and iron chelation therapy for a severe aplastic anemia patient undergoing hemodialysis due to chronic renal failure.

Authors:  Junji Hiraga; Reona Sakemura; Hiroshi Yamashita; Toshimitsu Suzuki; Satoshi Kitagawa; Yasunari Takakuwa; Shinichi Mizuno
Journal:  Int J Hematol       Date:  2011-03-23       Impact factor: 2.490

2.  Bone marrow mast cell reaction in preleukaemic myelodysplasia and in aplastic anaemia.

Authors:  I Fohlmeister; T Reber; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Challenges of caring for an advanced chronic kidney disease patient with severe thrombocytopenia.

Authors:  Tetsu Akimoto; Chiharu Ito; Atsushi Kotoda; Manabu Ogura; Taro Sugase; Ryuta Sato; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2013-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.